ZYUS fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
ZYUS Life Sciences Corp. is a Canadian-based life sciences company. It focuses on the global development and commercialization of cannabinoid based pharmaceutical drug product candidates and exempt market therapeutics. The firm offers cGMP/EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The company was founded by Zettl Harold Brent in April 2018 and is headquartered in Saskatoon, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ZYUS has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company